Tracked deals
38
38 tracked deals across 2018-2026.
Luxembourg, Luxembourg, Luxembourg
Pan-European private equity firm partnering with management teams to acquire and grow market-leading companies across healthcare, software, technology, business services and technology-based industrial sectors. Headquartered in Luxembourg with offices including London and Paris.
Tracked deals
38
38 tracked deals across 2018-2026.
Recent pace
3
3 tracked deals announced in the last 12 months.
Deal mix
Buyout
26 buyout · 6 addon · 4 growth capital
Last 9 years
Supporting Data
Showing the 12 most recent of 38 tracked deals for Astorg.
Solina USA acquired Epicurean Butter, a Denver-based developer and manufacturer of flavored compound butters and customized dairy flavor solutions. The deal expands Solina’s dairy innovation and flavor development capabilities, with Epicurean continuing to operate from its Denver facility under its existing leadership team.
Astorg has signed a definitive agreement to acquire Thermo Fisher Scientific’s global microbiology business in a carve-out transaction. The unit will operate as an independent, privately owned platform backed by Astorg, focused on antimicrobial susceptibility testing and microbiology diagnostics. The deal is expected to close in the second half of 2026 (and is later reported as completed in 2026).
Solabia, a Paris-headquartered biotech platform focused on natural active ingredients and diagnostics solutions, has agreed to acquire three complementary businesses as part of its international expansion strategy. The acquisitions include Switzerland-based Mibelle Biochemistry, France-based Seqens' Botanical Actives and In-Vitro Diagnostics activity, and Germany/Netherlands-based Xebios Group.
Astorg, a pan‑European private equity firm, has made an investment in ATTIKON Finanz AG, a leading German commercial insurance brokerage platform. Sigla remains invested alongside the founders and management; Astorg will support ATTIKON's buy‑and‑build strategy, digitization and expansion into MGA and complementary services.
Normec, a European testing, inspection, certification, and compliance (TICC) provider, entered the United States by acquiring three specialized laboratories: MS Bio, MJ Reider, and NorthEast BioLab. The acquisitions expand Normec’s addressable market and deepen capabilities across bioanalysis, water quality, and nutritional testing for regulated end markets including healthcare and food-related compliance.
Astorg has signed a definitive agreement to acquire a majority stake in Solabia Group from TA Associates, with TA reinvesting alongside Astorg. Solabia, a Paris-headquartered biotech ingredients manufacturer with 11 production sites, 8 R&D labs and over 900 employees, will partner with Astorg to accelerate international expansion (particularly in the US and Asia), advance product innovation and pursue targeted M&A.
Astorg has signed a definitive agreement to acquire FUJIFILM Irvine Scientific's Medical Media Business (Irvine Scientific MBU) from FUJIFILM Irvine Scientific, adding culture and vitrification media products to its recently combined assisted reproductive technology (ART) platform created from Hamilton Thorne and Cook Medical's Reproductive Health business. The deal is an add-on designed to create a global ART MedTech leader by expanding product capabilities for fertility clinics and IVF laboratories; financial terms were not disclosed.
Astorg completed a take-private of Hamilton Thorne and simultaneously acquired Cook Medical’s Reproductive Health business, combining the two to create a global leader in assisted reproductive technology (ART) consumables, instruments and equipment. The combined company will serve fertility clinics and IVF laboratories in over 115 countries, with a new executive team appointed to lead the integrated MedTech platform.
Astorg Mid-Cap (Astorg) has signed a binding agreement to acquire a majority stake in Redslim from its founders, who will reinvest significantly. The investment will support Redslim's international expansion, accelerate R&D and platform investments, and scale commercial and service teams to serve CPG and consumer healthcare clients.
Astorg has entered exclusive negotiations to acquire a majority stake in Lebronze alloys, a France-headquartered global leader in high-performance copper and nickel alloys. The investment would see Lebronze's Executive Chairman Michel Dumont remain a significant shareholder while Astorg supports growth initiatives including geographic expansion (notably the U.S. and India) and downstream service-center rollouts; financial terms were not disclosed.
Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.
Astorg Mid‑Cap will invest a 51% stake in Sofico in partnership with Sofico founders Gémar Hompes and Piet Maes and existing investor Apheon, with the founders and Apheon significantly reinvesting and remaining involved. Sofico, headquartered in Ghent, is a leading software provider for the automotive leasing and mobility industry, employs over 500 experts, serves major global leasing customers, and will use the partnership to accelerate product development, services expansion and M&A; financial terms were not disclosed and the deal is expected to close in Q1 2024.
Turn tracked acquisition activity into an outreach-ready buyer list.